These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of T-cell anergy and suppression in susceptibility to IDDM. Bergerot I; Arreaza G; Cameron M; Chou H; Delovitch TL Res Immunol; 1997 Jun; 148(5):348-58. PubMed ID: 9352600 [No Abstract] [Full Text] [Related]
5. [The autoimmune mechanisms of the development of insulin-dependent diabetes mellitus]. Shishko PI Ter Arkh; 1991; 63(6):l46-51. PubMed ID: 1948721 [No Abstract] [Full Text] [Related]
6. [Role of the thymus in the pathophysiology of autoimmune diabetes type 1]. Geenen V; Kecha O; Brilot F; Martens H; Lefebvre P Bull Mem Acad R Med Belg; 2000; 155(5-6):237-43; discussion 243-4. PubMed ID: 11304959 [TBL] [Abstract][Full Text] [Related]
7. Natural killer T cells: natural or unnatural regulators of autoimmunity? Hammond KJ; Kronenberg M Curr Opin Immunol; 2003 Dec; 15(6):683-9. PubMed ID: 14630203 [TBL] [Abstract][Full Text] [Related]
8. Thymic transcription of neurohypophysial and insulin-related genes: impact upon T-cell differentiation and self-tolerance. Hansenne I J Neuroendocrinol; 2005 May; 17(5):321-7. PubMed ID: 15869568 [TBL] [Abstract][Full Text] [Related]
9. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. Cardell SL Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042 [TBL] [Abstract][Full Text] [Related]
10. Immune regulation by invariant NKT cells in autoimmunity. Ronchi F; Falcone M Front Biosci; 2008 May; 13():4827-37. PubMed ID: 18508548 [TBL] [Abstract][Full Text] [Related]
11. Does lymphopenia preclude restoration of immune homeostasis? The particular case of type 1 diabetes. Askenasy EM; Askenasy N; Askenasy JJ Autoimmun Rev; 2010 Aug; 9(10):687-90. PubMed ID: 20624693 [TBL] [Abstract][Full Text] [Related]
12. Immunoregulation of autoimmunity by natural killer T cells. Linsen L; Somers V; Stinissen P Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406 [TBL] [Abstract][Full Text] [Related]
13. The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy. Fraker C; Bayer AL Curr Diab Rep; 2016 Nov; 16(11):109. PubMed ID: 27664042 [TBL] [Abstract][Full Text] [Related]
14. Characteristics of autoimmunity in type 1 diabetes and type 1.5 overlap with type 2 diabetes. McDevitt HO Diabetes; 2005 Dec; 54 Suppl 2():S4-10. PubMed ID: 16306338 [TBL] [Abstract][Full Text] [Related]
15. Intrinsic defects in the T-cell lineage results in natural killer T-cell deficiency and the development of diabetes in the nonobese diabetic mouse. Yang Y; Bao M; Yoon JW Diabetes; 2001 Dec; 50(12):2691-9. PubMed ID: 11723051 [TBL] [Abstract][Full Text] [Related]
16. A new look at MHC and autoimmune disease. Ridgway WM; Fassò M; Fathman CG Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398 [No Abstract] [Full Text] [Related]
17. The role of NK cells in autoimmune disease. Baxter AG; Smyth MJ Autoimmunity; 2002 Feb; 35(1):1-14. PubMed ID: 11908701 [TBL] [Abstract][Full Text] [Related]
18. Identification of self-antigen-specific T cells reflecting loss of tolerance in autoimmune disease underpins preventative immunotherapeutic strategies in rheumatoid arthritis. Law SC; Benham H; Reid HH; Rossjohn J; Thomas R Rheum Dis Clin North Am; 2014 Nov; 40(4):735-52. PubMed ID: 25437289 [TBL] [Abstract][Full Text] [Related]
19. High frequency of valpha24(+) vbeta11(+) T-cells observed in type 1 diabetes. Oikawa Y; Shimada A; Yamada S; Motohashi Y; Nakagawa Y; Irie J; Maruyama T; Saruta T Diabetes Care; 2002 Oct; 25(10):1818-23. PubMed ID: 12351484 [TBL] [Abstract][Full Text] [Related]
20. The use of idd congenic mice to identify checkpoints of peripheral tolerance to islet antigen. Hamilton-Williams EE; Martinez X; Lyman M; Hunter K; Wicker LS; Sherman LA Ann N Y Acad Sci; 2007 Apr; 1103():118-27. PubMed ID: 17376833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]